Neuphoria Therapeutics(DE:B1N0)
€1.610.00 (0.00%)
DE:B1N0
Neuphoria Therapeutics earnings date
€1.61
At close:0.00 (0.00%)
Neuphoria Therapeutics (B1N0) Q2 2023 Earnings Report
2 Followers
DE:B1N0 Q2 2023 EPS Results
- Actual EPS
- -EUR 15.49
- Consensus EPS
- -EUR 7.00
- Beat/Miss
- Missed by -EUR 8.49
- One Year Ago EPS
- -EUR 5.37
DE:B1N0 Q2 2023 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 245.81K
- Beat/Miss
- Missed by -EUR 245.81K
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 02/23/2023
- Time
- Before Open
- Conference Call
- Thursday, February 23, 2023
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:B1N0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Sep 29, 2025 | 2025 (Q4) | -1.82-2.31 | -25.64 | 91.00% (+23.33) | |
| Feb 20, 2025 | 2025 (Q2) | ―- | ― | ― | |
| Aug 21, 2024 | 2024 (Q4) | -0.83-0.83 | -0.93 | 10.23% (+0.09) | |
| Feb 22, 2024 | 2024 (Q2) | ―-0.93 | -1.29 | 28.10% (+0.36) | |
| Aug 23, 2023 | 2023 (Q4) | -0.98- | -1.01 | ― | |
| Feb 23, 2023 | 2023 (Q2) | -7.00-15.49 | -5.37 | -188.32% (-10.12) | |
| Aug 25, 2022 | 2022 (Q4) | ―-12.15 | -0.01 | -153677.78% (-12.14) | |
| Feb 22, 2022 | 2022 (Q2) | -10.79-5.37 | 0 | ― | |
| Aug 25, 2021 | 2021 (Q4) | 0.00-0.01 | 0 | ― | |
| Feb 26, 2021 | 2021 (Q2) | 0.000.00 | -0.98 | 100.00% (+0.98) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

